Graticule Asia Macro Advisors LLC Bristol Myers Squibb CO Transaction History

Graticule Asia Macro Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $614,376 - $796,698	-12,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $447,039 - $504,225	8,100 Added 180.0%	12,600 $782,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $45,477 - $56,682	900 Added 25.0%	4,500 $249,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $215,712 - $248,328	3,600 New	3,600 $228,000

2,478

1.49B

26M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $107B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.